m****g 发帖数: 530 | 1 We have met the enemy and he is us!
Vincent T. DeVita, Jr1 About the author
I would like to return to the subject of over regulation and how it is
sometimes of our own doing. My
editorial on the broken clinical trials program generated a fair amount of
discussion, including at my own
institution. In an article written about the editorial, Dr Alan Sandler
provided a startling additional piece of
information. At one institution, 87 steps and 29 signatures were required to
launch a trial (Helwick, | m****g 发帖数: 530 | 2 this article is from nature reviews clinical oncology.
利益集团的代言人就是这样制造舆论影响的!大家要好好学习啊! | a****o 发帖数: 1786 | 3 can you be more specific?
LZ, please comment on this comment, like Technical Comment and Reply in
Nature.
【在 m****g 的大作中提到】![](/moin_static193/solenoid/img/up.png) : this article is from nature reviews clinical oncology. : 利益集团的代言人就是这样制造舆论影响的!大家要好好学习啊!
| m****g 发帖数: 530 | 4 clinical regulation is the only way in america that the government still has
the control for the pharma industry. almost all the other issue are
controlled by a self organization formed by all these big pharma. in the
last two years, they have been focusing on firing the regulation hurdles to
obtain reasonable excuse for the lack of new product and hence the high
drug price ,and more importantly , resistant to obama's new health insurance
plan reform. if the clinical regulation get loosened | m****g 发帖数: 530 | 5 this is article is editorial, they basically represnet the journal's point
of view. From the scientific point of view, you can not attack them under
the principle that all science are free.
but the undertable view is that the words he is speaking is not supporting
the patients, the science, but only the pharma. that is politics. :) |
|